…
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ardent Health Partners operates and manages acute-care hospitals and outpatient facilities in the United States, providing inpatient, outpatient and ancillary services under an integrated operator-owner model. Long-term growth drivers include demographic aging, continued migration of care to lower-cost outpatient settings, and adoption of value-based payment approaches that could support steady demand and efficiency improvements. Investors may find the company attractive for its scale in essential healthcare services and potential to enhance margins through network optimization and operational initiatives.
Principal risks include exposure to reimbursement and regulatory changes, persistent labor and supply cost inflation, and competitive pressures that may constrain revenue growth and margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 286.36M | 363.06M | 151.61M | 311.48M | 295.89M |
| Minority interest | -94.32M | -89.36M | -72.65M | -76.46M | -90.32M |
| Net income | 135.81M | 210.34M | 50.29M | 188.91M | 154.26M |
| Selling general administrative | 1192.64M | 1097.12M | 3607.66M | 3371.68M | 3132.33M |
| Selling and marketing expenses | - | - | 14.87M | 956.26M | 906.98M |
| Gross profit | 6168.64M | 3431.32M | 4416.08M | 4174.52M | 3943.07M |
| Reconciled depreciation | 155.70M | 146.29M | 140.84M | 138.17M | 137.20M |
| Ebit | 325.58M | 409.63M | 209.15M | 393.53M | 389.72M |
| Ebitda | 481.29M | 555.92M | 350.00M | 531.70M | 526.92M |
| Depreciation and amortization | 155.70M | 146.29M | 140.84M | 138.17M | 137.20M |
| Operating income | 325.58M | 405.76M | 229.50M | 802.84M | 322.72M |
| Other operating expenses | 5998.76M | 5603.01M | 5179.98M | 5867.83M | 5361.16M |
| Interest expense | 55.20M | 65.58M | 65.42M | 82.05M | 93.83M |
| Tax provision | 56.22M | 63.35M | 20.78M | 46.11M | 51.31M |
| Net interest income | -55.20M | -65.58M | -65.42M | -82.05M | -93.83M |
| Income tax expense | 56.22M | 63.35M | 22.64M | 46.11M | 51.31M |
| Total revenue | 6324.34M | 5966.07M | 5409.48M | 5129.69M | 4870.40M |
| Total operating expenses | 5843.05M | 3068.26M | 5200.04M | 4912.66M | 4410.47M |
| Cost of revenue | 155.70M | 2534.76M | 993.40M | 955.17M | 927.33M |
| Total other income expense net | -39.23M | -42.70M | -77.89M | -491.36M | -26.83M |
| Net income from continuing ops | 230.13M | 299.71M | 122.94M | 265.37M | 244.58M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5290.21M | 4956.10M | 4731.56M | 4859.88M | - |
| Intangible assets | 89.33M | 76.93M | 76.93M | 76.93M | - |
| Other current assets | 544.53M | 417.84M | 299.57M | 234.01M | - |
| Total liab | 3605.24M | 3433.74M | 3649.24M | 3809.57M | - |
| Total stockholder equity | 1686.21M | 1521.20M | 670.90M | 639.05M | - |
| Other current liab | 565.16M | 519.74M | 422.49M | 387.48M | - |
| Common stock | 1.43M | 1.43M | 496.88M | 510.97M | - |
| Retained earnings | 501.61M | 365.80M | 155.45M | 101.55M | - |
| Good will | 879.45M | 852.08M | 844.70M | 844.70M | - |
| Other assets | - | - | -371.21M | - | - |
| Cash | 709.60M | 556.78M | 437.58M | 456.12M | - |
| Total current liabilities | 1046.54M | 945.42M | 994.10M | 808.60M | - |
| Current deferred revenue | - | - | 18.02M | 17.35M | - |
| Net debt | 1554.86M | 1725.40M | 1959.04M | 1932.23M | - |
| Short term debt | 23.44M | 55.62M | 61.03M | 65.63M | - |
| Short long term debt | 23.44M | 9.23M | 18.61M | 16.09M | - |
| Short long term debt total | 2264.46M | 2282.19M | 2396.62M | 2388.35M | - |
| Other stockholder equity | 1186.79M | 1144.24M | -174.01M | - | - |
| Total current assets | 2058.82M | 1832.75M | 1618.09M | 1409.25M | - |
| Short term investments | - | - | 8.70M | 21.40M | - |
| Net receivables | 686.10M | 743.03M | 775.45M | 611.96M | - |
| Long term debt | 1075.78M | 1085.82M | 1168.25M | 1161.90M | - |
| Inventory | 118.59M | 115.09M | 105.48M | 107.15M | - |
| Accounts payable | 457.94M | 401.25M | 474.54M | 320.80M | - |
| Accumulated other comprehensive income | -3.61M | 9.74M | 18.56M | 26.53M | - |
| Non currrent assets other | 111.69M | 142.97M | 138.01M | 93.98M | - |
| Non current assets total | 3231.38M | 3123.35M | 3113.47M | 3450.62M | - |
| Capital lease obligations | 1218.73M | 1187.14M | 1209.76M | 1210.37M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -220.46M | -137.98M | 46.58M | -136.26M |
| Total cashflows from investing activities | -214.23M | - | - | - | - |
| Net borrowings | -7.99M | - | - | - | - |
| Total cash from financing activities | -103.47M | 24.64M | -102.26M | -270.33M | -283.91M |
| Net income | 230.13M | 299.71M | 53.90M | 188.91M | 154.26M |
| Change in cash | 152.82M | 119.21M | -18.55M | -262.11M | 658.57M |
| Begin period cash flow | 556.78M | 437.58M | 456.12M | 718.24M | 59.66M |
| End period cash flow | 709.60M | 556.78M | 437.58M | 456.12M | 718.24M |
| Total cash from operating activities | 470.51M | 315.03M | 221.70M | -38.36M | 146.91M |
| Issuance of capital stock | 0.00M | 208.66M | 0.00M | 0.00M | - |
| Depreciation | 155.70M | 146.29M | 140.84M | 138.17M | 137.20M |
| Other cashflows from investing activities | 0.18M | -1.71M | -0.57M | -8.69M | 1.47M |
| Dividends paid | - | 0.00M | 0.00M | 174.81M | 62.13M |
| Change to inventory | -3.15M | -9.41M | 1.67M | 4.67M | -5.73M |
| Change to account receivables | 59.16M | 40.00M | -181.10M | -17.18M | -96.47M |
| Other cashflows from financing activities | -95.48M | -67.26M | -95.24M | -79.11M | -137.33M |
| Capital expenditures | 211.90M | 187.51M | 137.41M | 151.11M | 139.00M |
| Change in working capital | -3.34M | -181.75M | -56.31M | -325.65M | -261.12M |
| Stock based compensation | 39.29M | 17.98M | 0.90M | 0.61M | 0.55M |
| Other non cash items | 5.13M | 8.76M | 78.36M | -86.51M | 146.67M |
| Free cash flow | 258.61M | 127.52M | 84.29M | -189.47M | 7.91M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners, Inc. |
- -% |
17.30 | 10.58 | 9.09 | 0.23 | 1.10 | 0.48 | 6.09 |
| HCA HCA Healthcare, Inc. |
-12.49 2.46% |
494.99 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-3.13 1.09% |
283.33 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.06 0.42% |
14.62 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.28 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
340 Seven Springs Way, Brentwood, TN, United States, 37027
615 296 3000
19500
| Name | Title | Year Born |
|---|---|---|
| Mr. Martin J. Bonick FACHE, M.H.A. | President, CEO & Director | 1973 |
| Mr. Alfred Lumsdaine CPA | Chief Financial Officer | 1965 |
| Mr. Stephen Christopher Petrovich | Executive VP, General Counsel, Chief Legal Officer & Secretary | 1967 |
| Mr. David W. Schultz | President of Hospital Operations | 1971 |
| Jess Botros | Vice President of IT Strategy & Operations | NA |
| Mr. David Byers CPA | Senior VP & Chief Accounting Officer | 1981 |
| Mr. Lonnie Garrison PMP | Chief Technology Officer | NA |
| Ms. Anika Gardenhire B.S.N., R.N. | Chief Digital & Information Officer | 1983 |
| Mr. David Anthony Styblo C.F.A. | Senior Vice President of Investor Relations | NA |
| Mr. Jason Ehrlinspiel | Chief Compliance Officer | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.